Zenday App vs Lose It!: a deficit tracker on a drug that already creates the deficit

Why does a GLP-1 need its own app at all?

Because the medication changes what the problem is. Appetite drops sharply, often unevenly across the dose cycle, and the old skill — eating less than you want — stops being the thing you need help with. Three new problems take its place: getting enough protein into a much smaller appetite, protecting muscle during rapid loss, and getting through the side-effect weeks that follow every dose increase.

Side effects are the single most common reason people stop treatment. That's the failure mode a GLP-1 companion exists to prevent, and it's the reason a general-purpose tracker struggles here no matter how good it is at its own job.

Zenday App was founded in 2025 by Emily Carter, who was taking a GLP-1 herself, and built with a doctor-led team. It now reports more than a million users. Its three pillars are dose-linked daily guidance, side-effect management, and privacy — it runs in a browser, so there's no app icon on your phone and no app-store purchase trail.

What happens when the app and the drug do the same job?

Lose It! sets a calorie budget and helps you stay under it. A GLP-1 suppresses appetite so that staying under it happens without effort. Run both together and you get a compounding effect that nobody designed: an app applauding a deficit that the medication has already made larger than intended.

The consequence isn't a slower result. It's a worse one — rapid loss with insufficient protein means a greater share of that loss is lean tissue, and lean tissue is the thing that keeps the weight off afterwards.

Zenday App inverts the priority. Protein and adequate intake come first; the deficit takes care of itself. That's a small change in framing that turns out to matter a lot over six months.

Is the price difference meaningful?

Lose It! at around $39.99 a year is genuinely good value, and about $49 less than Zenday App's Plus tier. Set against a medication costing $500–$1,000 a month, though, the difference is roughly four hours of prescription. The relevant question isn't which app is cheaper — it's which one protects the money you're already spending.

What Lose It! is genuinely best at

No app in this comparison is bad, and pretending otherwise would make this page less useful. Here's where Lose It! leads:

• Approachability — it's one of the least intimidating trackers for a first-time logger
• Snap It photo logging, which is quick and forgiving
• Price: premium at roughly $39.99 a year undercuts most of the category
• Social challenges, which genuinely help some people stay consistent

The cost framing that actually matters

GLP-1 medication commonly runs $500–$1,000 a month. Against that, the difference between two companion apps is a rounding error — usually less than two days of prescription. The question worth asking isn't which app is cheaper. It's which one makes the expensive thing work harder, and which one keeps you on treatment through the weeks when most people stop.